Use of IP Chemotherapy in Ovarian Cancer: The Critical Questions THE GONZALEZ/GREEN/MUGGIA ARTICLE REVIEWED

被引:0
|
作者
Trimble, Edward L. [1 ]
Fujiwara, Keiichi [2 ]
Marth, Christian [3 ]
Abrams, Jeffrey [1 ]
机构
[1] NCI, Bethesda, MD 20892 USA
[2] Saitama Med Univ, Int Med Ctr, Saitama, Japan
[3] Innsbruck Med Univ Hosp, Innsbruck, Austria
来源
ONCOLOGY-NEW YORK | 2011年 / 25卷 / 02期
关键词
INTRAPERITONEAL CHEMOTHERAPY; SURVIVAL; SURGERY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:170 / 174
页数:3
相关论文
共 31 条
  • [31] The Use of CA-125 KELIM to Identify Which Patients Can Achieve Complete Cytoreduction after Neoadjuvant Chemotherapy in High-Grade Serous Advanced Ovarian Cancer
    Zouzoulas, Dimitrios
    Tsolakidis, Dimitrios
    Tzitzis, Panagiotis
    Sofianou, Iliana
    Chatzistamatiou, Kimon
    Theodoulidis, Vasilis
    Topalidou, Maria
    Timotheadou, Eleni
    Grimbizis, Grigoris
    CANCERS, 2024, 16 (07)